SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-015761
Filing Date
2020-11-05
Accepted
2020-11-05 16:23:21
Documents
46
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q advm-20200930.htm   iXBRL 10-Q 1243441
2 EX-31.1 advm-20200930ex311.htm EX-31.1 9968
3 EX-31.2 advm-20200930ex312.htm EX-31.2 9983
4 EX-32.1 advm-20200930ex321.htm EX-32.1 5196
5 EX-32.2 advm-20200930ex322.htm EX-32.2 7197
  Complete submission text file 0001628280-20-015761.txt   3952718

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20200930.xsd EX-101.SCH 20438
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20200930_cal.xml EX-101.CAL 52910
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20200930_def.xml EX-101.DEF 86357
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20200930_lab.xml EX-101.LAB 317277
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20200930_pre.xml EX-101.PRE 186625
11 EXTRACTED XBRL INSTANCE DOCUMENT advm-20200930_htm.xml XML 568062
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 201290817
SIC: 2836 Biological Products, (No Diagnostic Substances)